MoodMon for Psychiatrists

Extend Patient Monitoring Beyond Clinical Appointments

MoodMon is a CE-marked Class IIa medical device that uses artificial intelligence to support the continuous, objective monitoring of patients diagnosed with bipolar disorder and recurrent depression.

Features

How MoodMon Fits Into Your Clinical Practice

By analyzing physical parameters of patients’ voices, MoodMon helps psychiatrists identify potentially clinically relevant changes in their mental state between appointments, supporting timely clinical assessment and more informed treatment decisions. MoodMon is designed to complement psychiatric care, not replace clinical judgment.

01.

Onboard your patient

Introduce MoodMon to your patient and complete the onboarding process. The patient starts using the MoodMon mobile app, while you gain access to their monitoring information through the dedicated psychiatrist web portal.

02.

Monitor AI-generated alerts

MoodMon analyzes voice parameters daily and generates an alert when it detects patterns suggesting a potentially clinically relevant change in the patient’s mental state.

Alerts are not sent to psychiatrists as automatic push notifications. They are available when you log in to the MoodMon web portal, allowing you to review them as part of your clinical workflow.

Integration with your existing Electronic Health Record (EHR) system may also be possible, enabling alerts to be delivered within your clinical software. Integration options and technical requirements are agreed individually.

03.

Assess the patient and decide on next steps

When an alert is generated, we recommend contacting the patient within 72 hours.

During a phone consultation, you assess whether a clinically relevant change has actually occurred and determine whether further action is necessary. Depending on your clinical assessment, this may involve scheduling an additional appointment, adjusting treatment, or continuing routine monitoring.

04.

Document your clinical assessment

Record your evaluation of the alert in the MoodMon web portal, including whether the alert was clinically justified.

You can also review complementary information on the patient’s sleep, physical activity, and smartphone usage to support your assessment.

Your clinical feedback contributes to the further development and refinement of MoodMon’s AI algorithms.

Validation

Clinically Validated AI

MoodMon has undergone prospective clinical validation involving patients diagnosed with bipolar disorder and recurrent depression.

The results demonstrate the system’s potential to support psychiatrists in monitoring patients between appointments and identifying changes that may require clinical attention.

MoodMon was clinically validated in a prospective study covering more than 31,000 patient-days of monitoring, achieving 89.5% sensitivity and 98.8% specificity in detecting clinically relevant changes in patients’ mental state.
MoodMon is a CE-marked Class IIa medical device under Regulation (EU) 2017/745 (MDR).

Benefits

Clinical benefits observed in the MoodMon’s Clinical Study

The clinical study identified the following key benefits of MoodMon for patients with affective disorders:

01.

Improved Therapy Personalization and Early Intervention

MoodMon enables more precise adjustment of treatment according to the patient’s current mental state, allowing earlier interventions in case of symptom exacerbation.

02.

Significant Reduction in Hospitalizations

A major outcome of the study was a marked reduction in hospitalizations:

During the study period, no hospitalizations due to affective disorder occurred among monitored patients.
In the same patient group
In the same patient group during the same period before the study, 12 hospitalizations were recorded.

03.

Support for Medical Personnel Shortages

MoodMon provides clinical support that is particularly valuable in the context of growing psychiatrist shortages, helping to manage the increasing number of patients requiring specialized care.

The reported sensitivity and specificity refer to the clinical validation study. MoodMon supports clinical monitoring and does not independently diagnose psychiatric conditions or replace professional medical assessment.

Partnership

Partner With MoodMon – A Business Model for Your Practice

MoodMon offers psychiatrists running their own private practices an opportunity to introduce AI-supported patient monitoring as an additional service. Our cooperation model is designed to recognize both the value of continuous monitoring and the physician’s clinical involvement.

Shared Subscription Revenue

Patients pay a subscription fee for using MoodMon. We share the subscription revenue with the cooperating psychiatrist, creating an additional recurring revenue opportunity for your practice.

Compensation for Clinical Work

Our cooperation model also recognizes the work involved in onboarding patients and reviewing and assessing alerts. The specific remuneration structure is agreed as part of the cooperation arrangement.

Flexible Implementation

MoodMon can be introduced into your existing practice without replacing your current clinical software. Where technically feasible, integration with your EHR system can be explored and agreed individually.

We would be happy to discuss a cooperation model tailored to your practice and patient population.

Contact form

Interested in Using MoodMon in Your Practice?

Discover how MoodMon could support your patients and become part of your clinical workflow. Leave us your contact details, and our team will get in touch to discuss cooperation opportunities, explain the onboarding process, or arrange a product demonstration.